Glucose regulation in young adults with very low birth weight

Petteri Hovi1, Sture Andersson, Johan G Eriksson

  • 1Department of Health Promotion and Chronic Disease Prevention, National Public Health Institute, Helsinki, Finland. petteri.hovi@helsinki.fi

Insights

Young adults born with very low birth weight exhibit impaired glucose regulation and higher blood pressure. These findings highlight long-term metabolic health risks associated with extremely low birth weight.

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Perinatal Medicine

Background:

  • Impaired glucose regulation is linked to small size at birth in term-born individuals.
  • Preterm birth with very low birth weight (<1500 g) is associated with childhood insulin resistance.
  • Persistent insulin resistance may increase adult disease risk for very low birth weight survivors.

Purpose of the Study:

  • To assess glucose tolerance and insulin sensitivity in young adults with very low birth weight.
  • To measure serum lipid levels and blood pressure in this cohort.
  • To compare metabolic and cardiovascular markers with term-born controls.

Main Methods:

  • 163 very low birth weight young adults and 169 term-born controls underwent a 75-g oral glucose-tolerance test.
  • Insulin and glucose concentrations were measured at baseline and 120 minutes.
  • Blood pressure, serum lipids, and body composition (dual-energy x-ray absorptiometry) were assessed.

Main Results:

  • Very low birth weight subjects showed increased 2-hour glucose (6.7%) and fasting insulin (16.7%).
  • Higher 2-hour insulin (40.0%) and insulin resistance index (18.9%) were observed in the very low birth weight group.
  • Systolic blood pressure was elevated by 4.8 mm Hg in very low birth weight adults, independent of lean body mass.

Conclusions:

  • Young adults with very low birth weight demonstrate significantly higher insulin resistance.
  • Glucose intolerance is more prevalent in young adults with a history of very low birth weight.
  • Elevated blood pressure is a key finding in this cohort, suggesting long-term cardiovascular implications.
Abstract

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...